» Articles » PMID: 31118722

Barriers of Medication Adherence in Patients with Type-2 Diabetes: a Pilot Qualitative Study

Overview
Publisher Dove Medical Press
Specialty Endocrinology
Date 2019 May 24
PMID 31118722
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with type-2 diabetes have poor adherence to the therapeutic regime. It can result in various complications in body systems associated with undesirable metabolic control. The present study aimed to explore the inhibitors of medication adherence in patients with type-2 diabetes. This was a qualitative study using a conventional content analysis method. Participants were 12 patients with type-2 diabetes referred to the diabetes unit in Saghez, Kurdistan Province in 2015. The purposive sampling method was used with a maximum variation in sampling, and data collection was continued until data saturation was achieved. Semi-structured interviews were used for data collection. Interviews were recorded and immediately transcribed verbatim. Data analysis led to the development of four main categories including disbelief in medical explanatory/prescriptive knowledge, lived experiences of the disease, challenges of everyday life, and interactive/economic challenges. The main inhibitors were the patient's understanding of his/her own physical status and strategies used for maintaining the internal balance. Healthcare providers need to take patients' perceptions into account when they are prescribing medicinal diets. Another inhibitor was the incidents of everyday life, including economic and social challenges, and interactions to receive education and skills for living with the disease. Beliefs of the medical team and patients should be brought closer to each other, and patients' trust in the medical team should be increased. Nurses should consider the unique experience of every patient when giving healthcare recommendations, and try to limit the existing challenges as much as possible.

Citing Articles

Stakeholder perspectives on facilitators and barriers to implementing a zero-dollar copay program for chronic conditions study.

Winberg D, Nauman E, Shi L, Mohundro B, Louis K, Price-Haywood E Health Res Policy Syst. 2025; 23(1):6.

PMID: 39762862 PMC: 11702045. DOI: 10.1186/s12961-024-01278-5.


Availability and affordability of diabetes healthcare services associated with the frequency of diabetes-related complications.

Alijanzadeh M, Hashemipour S, Attaran F, Saremi S, Modarresnia L, Ghafelehbashi H BMC Health Serv Res. 2024; 24(1):1586.

PMID: 39695678 PMC: 11654362. DOI: 10.1186/s12913-024-12065-x.


The Effect of a cognitive behavioral program based on an interactive application on serum glucose levels and HbA1C of family members of patients with type 2 diabetes: a study protocol for a randomized clinical trial.

Bahramnezhad F, Jackson A, Ghorbani B, Kahnouei M, Sharifi F, Negarandeh R J Diabetes Metab Disord. 2024; 23(2):2385-2393.

PMID: 39610530 PMC: 11599702. DOI: 10.1007/s40200-023-01183-8.


Photobiomodulation studies on diabetic wound healing: An insight into the inflammatory pathway in diabetic wound healing.

Mgwenya T, Abrahamse H, Houreld N Wound Repair Regen. 2024; 33(1):e13239.

PMID: 39610015 PMC: 11628774. DOI: 10.1111/wrr.13239.


Investigating the Effects of Gossypetin on Cardiovascular Function in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats.

Naidoo K, Khathi A Int J Mol Sci. 2024; 25(22).

PMID: 39596174 PMC: 11594263. DOI: 10.3390/ijms252212105.


References
1.
Balkrishnan R, Rajagopalan R, Camacho F, Huston S, Murray F, Anderson R . Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003; 25(11):2958-71. DOI: 10.1016/s0149-2918(03)80347-8. View

2.
Graneheim U, LUNDMAN B . Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004; 24(2):105-12. DOI: 10.1016/j.nedt.2003.10.001. View

3.
Lerman I . Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res. 2005; 36(3):300-6. DOI: 10.1016/j.arcmed.2004.12.001. View

4.
Hertz R, Unger A, Lustik M . Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005; 27(7):1064-73. DOI: 10.1016/j.clinthera.2005.07.009. View

5.
Ho P, Rumsfeld J, Masoudi F, McClure D, Plomondon M, Steiner J . Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006; 166(17):1836-41. DOI: 10.1001/archinte.166.17.1836. View